(NYSE: AVNT) Avient's forecast annual revenue growth rate of 4% is not forecast to beat the US Specialty Chemicals industry's average forecast revenue growth rate of 12.63%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 12.94%.
Avient's revenue in 2026 is $3,416,200,000.On average, 13 Wall Street analysts forecast AVNT's revenue for 2026 to be $325,422,480,292, with the lowest AVNT revenue forecast at $310,192,671,516, and the highest AVNT revenue forecast at $336,798,963,956. On average, 13 Wall Street analysts forecast AVNT's revenue for 2027 to be $339,551,339,036, with the lowest AVNT revenue forecast at $320,284,713,476, and the highest AVNT revenue forecast at $353,863,689,452.
In 2028, AVNT is forecast to generate $351,937,026,896 in revenue, with the lowest revenue forecast at $332,945,638,844 and the highest revenue forecast at $367,900,802,360.